We are happy that Gervasio A Lamas, M.D. will join us as a guest speaker. Dr. Lamas is chair of medicine and chief of cardiology at Mount Sinai Medical Center and was the lead investigator of the TACT trial (Trial to Assess Chelation Therapy). He initiated this multi-center double-blinded clinical trial, which took 10 years to be completed, to evaluate the efficacy and safety of EDTA chelation for the treatment of coronary and peripheral artery disease. The results of the trial surprised the medical world, including Lamas, and led to further large-scale trials on chelation therapy (TACT2, TACT3a).

Dr. Isabelle Schiffer will give an overview of the research that Forever Healthy conducted to evaluate the use of EDTA chelation therapy for vascular rejuvenation. The foundation identified over 2000 publications and included 111 relevant studies to assess the risks and the benefits of chelation therapy.

Summary of event available at: https://liveforever.club/article/summary-of-dr-gervasio-lamas-presentation-on-edta-clinical-trial